Literature DB >> 22868938

Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients.

Anne Beck1, Torsten Wüstenberg, Alexander Genauck, Jana Wrase, Florian Schlagenhauf, Michael N Smolka, Karl Mann, Andreas Heinz.   

Abstract

CONTEXT: In alcohol-dependent patients, brain atrophy and functional brain activation elicited by alcohol-associated stimuli may predict relapse. However, to date, the interaction between both factors has not been studied.
OBJECTIVE: To determine whether results from structural and functional magnetic resonance imaging are associated with relapse in detoxified alcohol-dependent patients.
DESIGN: A cue-reactivity functional magnetic resonance experiment with alcohol-associated and neutral stimuli. After a follow-up period of 3 months, the group of 46 detoxified alcohol-dependent patients was subdivided into 16 abstainers and 30 relapsers.
SETTING: Faculty for Clinical Medicine Mannheim at the University of Heidelberg, Germany. PARTICIPANTS: A total of 46 detoxified alcohol-dependent patients and 46 age- and sex-matched healthy control subjects MAIN OUTCOME MEASURES: Local gray matter volume, local stimulus-related functional magnetic resonance imaging activation, joint analyses of structural and functional data with Biological Parametric Mapping, and connectivity analyses adopting the psychophysiological interaction approach.
RESULTS: Subsequent relapsers showed pronounced atrophy in the bilateral orbitofrontal cortex and in the right medial prefrontal and anterior cingulate cortex, compared with healthy controls and patients who remained abstinent. The local gray matter volume-corrected brain response elicited by alcohol-associated vs neutral stimuli in the left medial prefrontal cortex was enhanced for subsequent relapsers, whereas abstainers displayed an increased neural response in the midbrain (the ventral tegmental area extending into the subthalamic nucleus) and ventral striatum. For alcohol-associated vs neutral stimuli in abstainers compared with relapsers, the analyses of the psychophysiological interaction showed a stronger functional connectivity between the midbrain and the left amygdala and between the midbrain and the left orbitofrontal cortex.
CONCLUSIONS: Subsequent relapsers displayed increased brain atrophy in brain areas associated with error monitoring and behavioral control. Correcting for gray matter reductions, we found that, in these patients, alcohol-related cues elicited increased activation in brain areas associated with attentional bias toward these cues and that, in patients who remained abstinent, increased activation and connectivity were observed in brain areas associated with processing of salient or aversive stimuli.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868938     DOI: 10.1001/archgenpsychiatry.2011.2026

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  101 in total

1.  Random forest based classification of alcohol dependence patients and healthy controls using resting state MRI.

Authors:  Xi Zhu; Xiaofei Du; Mike Kerich; Falk W Lohoff; Reza Momenan
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

2.  Mefenamic Acid Attenuates Chronic Alcohol Induced Cognitive Impairment in Zebrafish: Possible Role of Cholinergic Pathway.

Authors:  Venugopalan Rajesh; Mohanan Mridhulmohan; Subramanian Jayaseelan; Palanivel Sivakumar; Vellaiyachamy Ganesan
Journal:  Neurochem Res       Date:  2018-05-23       Impact factor: 3.996

3.  To drink or not to drink: Harmful drinking is associated with hyperactivation of reward areas rather than hypoactivation of control areas in men.

Authors:  Heiner Stuke; Stefan Gutwinski; Corinde E Wiers; Timo T Schmidt; Sonja Gröpper; Jenny Parnack; Christiane Gawron; Catherine Hindi Attar; Stephanie Spengler; Henrik Walter; Andreas Heinz; Felix Bermpohl
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

4.  Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics.

Authors:  Joseph P Schacht; Raymond F Anton; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

5.  Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.

Authors:  Doug Hyun Han; Sun Mi Kim; Jung Eun Choi; Kyung Joon Min; Perry F Renshaw
Journal:  J Psychopharmacol       Date:  2013-01-16       Impact factor: 4.153

6.  Developmental Trajectories of the Orbitofrontal Cortex and Anhedonia in Middle Childhood and Risk for Substance Use in Adolescence in a Longitudinal Sample of Depressed and Healthy Preschoolers.

Authors:  Joan L Luby; Arpana Agrawal; Andy Belden; Diana Whalen; Rebecca Tillman; Deanna M Barch
Journal:  Am J Psychiatry       Date:  2018-03-21       Impact factor: 18.112

Review 7.  Annual research review: Current limitations and future directions in MRI studies of child- and adult-onset developmental psychopathologies.

Authors:  Guillermo Horga; Tejal Kaur; Bradley S Peterson
Journal:  J Child Psychol Psychiatry       Date:  2014-01-20       Impact factor: 8.982

8.  White matter microstructural correlates of relapse in alcohol dependence.

Authors:  Yukai Zou; Donna E Murray; Timothy C Durazzo; Thomas P Schmidt; Troy A Murray; Dieter J Meyerhoff
Journal:  Psychiatry Res Neuroimaging       Date:  2018-09-18       Impact factor: 2.376

Review 9.  Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies.

Authors:  Agnes J Jasinska; Elliot A Stein; Jochen Kaiser; Marcus J Naumer; Yavor Yalachkov
Journal:  Neurosci Biobehav Rev       Date:  2013-11-06       Impact factor: 8.989

10.  A preliminary study of longitudinal neuroadaptation associated with recovery from addiction.

Authors:  Sarah E Forster; Peter R Finn; Joshua W Brown
Journal:  Drug Alcohol Depend       Date:  2016-09-09       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.